Evidence and Clinical Judgment: Vena cava filters

Davide Imberti; Francesco Dentali; Walter Ageno; Mark Crowther; David Garcia; Menno Huisman; Francesco Rodeghiero; Armando D’Angelo; Gualtiero Palareti

doi:10.1160/TH13-11-0938

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2014; 111(04): 618-624
DOI: 10.1160/TH13-11-0938

SISET Guideline Series

Schattauer GmbH

Evidence and Clinical Judgment^[*]: Vena cava filters

Authors

Davide Imberti

¹Department of Internal Medicine, Hospital of Piacenza, Piacenza, Italy
Francesco Dentali

²Department of Clinical Medicine, University of Insubria, Varese, Italy
Walter Ageno

²Department of Clinical Medicine, University of Insubria, Varese, Italy
Mark Crowther

³Department of Medicine, McMaster University, Hamilton, Canada
David Garcia

⁴Department of Medicine, University of Washington, Seattle, Washington, USA
Menno Huisman

⁵Department of Thrombosis and Hemostasis, Leiden, University Medical Center, Leiden, The Netherlands
Francesco Rodeghiero

⁶Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Armando D’Angelo

⁷Coagulation Service and Thrombosis Research Unit, Scientific Institute Ospedale San Raffaele, Milano, Italy
Gualtiero Palareti

⁸Department of Angiology, University of Bologna, Bologna, Italy

Abstract

Full Text

References

References
1 White RH. The epidemiology of venous thromboembolism.. Circulation 2003; 107: I-4-I-8.
2 Kearon C, Akl EA, Comerota AJ. et al. Antithrom-botic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.. Chest 2012; 141: e419S-e494S.
3 Stein PD, Kayali F, Olson RE. Twenty-one year trends in the use of inferior vena cava filters.. Arch Intern Med 2004; 164: 1541-1545.
4 Crowther M. Inferior vena cava filters in the management of venous thromboembolism.. Am J Med 2007; 120 (Suppl. 02) S13-17.
5 Spencer FA, Bates SM, Goldberg RJ. et al. A population-based study of inferior vena cava filters in patients with acute venous thromboembolism.. Arch Intern Med 2010; 170: 1456-1462.
6 Young T, Tang H, Hughes R. Vena caval filters for the prevention of pulmonary embolism.. Cochrane Database Syst Rev 2010; 2: CD006212.
7 Athanasoulis C. Inferior vena cava filters: review of a 26-year single center clinical experience.. Radiology 2000; 216: 54-66.
8 Hajduk B, Tomkowski WZ, Malek G, Davidson BL. Vena cava filter occlusion and venous throm-boembolism risk in persistently anticoagulated patients: a prospective, observational cohort study.. Chest 2010; 137: 877-882.
9 Imberti D, Ageno W, Manfredini R. et al. Interven-tional treatment of venous thromboembolism: a review.. Thromb Res 2012; 129: 418-425.
10 Duszak R, Parker L, Levin D. et al. Placement and removal of inferior vena cava filters: national trends in the Medicare population.. J Am Coll Radiol 2011; 89: 483-489.
11 Imberti D, Ageno W, Dentali F. et al. Retrievable vena cava filters: a clinical review.. J Thromb Thrombolysis 2012; 33: 258-266.
12 Gould MK, Garcia DA, Wren SM. et al. Prevention of VTE in Nonorthopedic Surgical Patients: Anti-thrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.. Chest 2012; 141: e227S-e277S.
13 Ageno W, Dentali F, Squizzato A. et al. Evidence and clinical judgment: Treatment of cerebral vein thrombosis.. ThrombHaemost 2010; 103: 1109-1115.
14 Decousus H, Leizorovicz A, Parent F. et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group.. N Engl J Med 1998; 338: 409-415.
15 PREPIC Study Group.. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study.. Circulation 2005; 112: 416-422.
16 Fox MA, Kahn SR. Postthrombotic syndrome in relation to vena cava filter placement: a systematic review.. J Vasc Interv Radiol 2008; 19: 981-985.
17 Johnson MS, Nemcek Jr. AA, Benenati JF. et al. The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study.. J Vasc Interv Radiol 2010; 21: 1173-1184.
18 Usoh F, Hingorani A, Ascher E. et al. Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters.. J Vasc Surg 2010; 52: 394-399.
19 Oliva VL, Szatmari F, Giroux MF. et al. The Jonas study: evaluation of the retrievability of the Cordis OptEase inferior vena cava filter.. J Vasc Interv Radiol 2005; 16: 1439-1445.
20 Imberti D, Bianchi M, Farina A. et al. Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study.. J Thromb Haemost 2005; 3: 1370-1375.
21 Wilkens H, Lang I, Behr J. et al. Chronic throm-boembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011.. Int J Cardiol 2011; 154 (Suppl. 01) S54-60.
22 Kim NH, Delcroix M, Jenkins DP. et al. Chronic thromboembolic pulmonary hypertension.. J Am Coll Cardiol 2013; 62 (Suppl. 025) D92-99.
23 Mismetti P, Ennezat PV, Quere I. et al. Prevention of pulmonary embolism recurrences by retrievable vena cava filter: results of the randomized multicenter trial PREPIC 2. XXIV.. ISTH Congress. 2013 Abstract AS 18.2.
24 Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism.. Circulation 2006; 113: 577-582.
25 Mismetti P. Randomized trial assessing the efficacy of the partial interruption of the inferior vena cava by an optional vena caval filter in the prevention of the recurrence of pulmonary embolism. PREPIC 2 trial: prevention of embolic recurrences by caval interruption (prospective, multi-centric, randomised, open trial).. Rev Pneumol Clin 2008; 64: 328-331.

Evidence and Clinical Judgment[*]: Vena cava filters

Authors

Evidence and Clinical Judgment^[*]: Vena cava filters